Artículos por temáticas

Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward

Silva RPDS, Barbosa BJAP.

J Alzheimers Dis. 2025 Mar;104(2):331-333. doi: 10.1177/13872877251316572. Epub 2025 Feb 9.

Reactive Oxygen Species as a Common Pathological Link Between Alcohol Use Disorder and Alzheimer's Disease with Therapeutic Implications

Song H, Lee J, Lee Y, Kim S, Kang S.

Int J Mol Sci. 2025 Apr 1;26(7):3272. doi: 10.3390/ijms26073272.

Caregiving outcomes among informal caregivers of persons with multimorbidity and dementia: a scoping review

Liu R, Peak K, Trubits E, Quiñones AR.

Eur Geriatr Med. 2025 Apr;16(2):485-524. doi: 10.1007/s41999-024-01150-3. Epub 2025 Feb 19.

Interferon Regulatory Factors as a Potential Therapeutic Target for Neuroinflammation: A Focus on Alzheimer's Disease

Fan X, Diao W, Wang H, Yin X, Qian W.

Int J Mol Sci. 2025 Mar 23;26(7):2906. doi: 10.3390/ijms26072906.

Role of mitogen-activated protein kinase inhibitors in Alzheimer's disease: Rouge of brain kinases

Almasoudi SH, Al-Kuraishy HM, Al-Gareeb AI, Eliwa D, Alexiou A, Papadakis M, Batiha GE.

Brain Res Bull. 2025 May;224:111296. doi: 10.1016/j.brainresbull.2025.111296. Epub 2025 Mar 10.

Lipoic acid scaffold applications in the design of multitarget-directed ligands against Alzheimer's disease

Manavi MA, Nourhashemi M, Emami S, Fathian Nasab MH, Dehnavi F, Küçükkılınç TT, Foroumadi A, Sharifzadeh M, Khoobi M.

Bioorg Chem. 2025 Apr;157:108241. doi: 10.1016/j.bioorg.2025.108241. Epub 2025 Feb 3.

Clinical Pharmacokinetics of Oral ALZ-801/Valiltramiprosate in a 2-Year Phase 2 Trial of APOE4 Carriers with Early Alzheimer's Disease

Hey JA, Yu JY, Abushakra S, Schaefer JF, Power A, Kesslak P, Paul J, Tolar M.

Clin Pharmacokinet. 2025 Mar;64(3):407-424. doi: 10.1007/s40262-025-01482-8. Epub 2025 Feb 5.

Potential benefits of marine-derived compounds for slowing the advancement of Alzheimer's disease

Malan A, Choudhary M, Kaur Bamrah P, Kumari D.

J Asian Nat Prod Res. 2025 Apr;27(4):479-504. doi: 10.1080/10286020.2024.2409869. Epub 2024 Oct 7.

The neuroinflammatory role of microRNAs in Alzheimer's disease: pathological insights to therapeutic potential

Liu W, Rao X, Sun W, Chen X, Yu L, Zhang J, Chen J, Zheng X.

Mol Cell Biochem. 2025 May;480(5):2689-2706. doi: 10.1007/s11010-024-05164-0. Epub 2024 Nov 20.

Brain health clinics - An evolving clinical pathway?

Butters AF, Blackman J, Farouk H, Meky S, A Newson M, Lemke T, Rosewell N, Selwood JA, Turner NL, Coulthard EJ, Archer HA.

J Prev Alzheimers Dis. 2025 Mar;12(3):100051. doi: 10.1016/j.tjpad.2024.100051. Epub 2025 Feb 3.

Effects of whole-head 810 nm near-infrared therapy on cognitive and neuropsychiatric symptoms in Alzheimer's disease: A pilot study

Guo R, Li D, Li F, Ji L, Liu H, Qiao H, Lv Z, Tang Y, Wang D.

J Alzheimers Dis. 2025 Mar;104(1):52-60. doi: 10.1177/13872877251313819. Epub 2025 Feb 5.

Annual societal cost of Alzheimer's disease in Malaysia: a micro-costing approach

Ong SC, Tay LX, Ong HM, Tiong IK, Ch'ng ASH, Parumasivam T.

BMC Geriatr. 2025 Mar 6;25(1):154. doi: 10.1186/s12877-025-05717-y.

Association of antioxidants intake in diet and supplements with risk of Alzheimer's disease: a systematic review and dose-response meta-analysis of prospective cohort studies

Hu X, Zhou J, Sun Y, Wang Z.

Aging Clin Exp Res. 2025 May 26;37(1):166. doi: 10.1007/s40520-024-02893-6.

Going beyond ATP binding site as a novel inhibitor design strategy for tau protein kinases in the treatment of Alzheimer's disease: A review

Zaater MA, El Kerdawy AM, Mahmoud WR, Abou-Seri SM.

Int J Biol Macromol. 2025 May;307(Pt 3):142141. doi: 10.1016/j.ijbiomac.2025.142141. Epub 2025 Mar 14.

Longitudinal comparative analysis of antidepressants and anti-anxiety medications in Alzheimer's and Parkinson's diseases: insights from French and British health records

Hamieh N, Ansart M, Guinebretiere O, Lekens B, Gantzer L, Durrleman S, Nedelec T.

J Affect Disord. 2025 Aug 1;382:148-153. doi: 10.1016/j.jad.2025.04.094. Epub 2025 Apr 20.